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Abstract: Meningiomas are well known for
their diverse histological apperance. Although
generally considered benign, their behaviour
is unpredictable and characterized by frequent recurrences. Histopathological features
associated with aggressive behaviour have
been described, but even the World Health
Organization (WHO) grading system provides
broad criteria for malignancy. Mahmood et
al. described a scoring system, based on 6
histopathological features, establishing objective criteria. In this study, 73 specimens
from 61 cases which were diagnosed as meningioma have been reviewed and scored by
the criteria described by Mahmood et al. in
order to search for the availability of the application of the system.
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Meningiomas have been recognised as an entitiy for
nearly two centuries (1). They are well known for
their diverse histological apperance, and it is related to
the multipotential character of the aracnoidal cap cells,
which is known to give rise to intracranial meningiomas (2). Of the many histological subtypes of
meningiomas recognised, only papillary variant is
known to have aggressive behaviour (3). Althought
generally considered benign, their behaviour is unpredictable and characterised by frequent recurrences
(1). Jaaskleinen et al. (4) and Rohringer et al. (5) attempted to classify these tumors into four groups by
usnig a numerical grading system, their grading criteria were not completely elucidated and are therefore
subjective. Also WHO classification (6) system provides
the broad criteria for malignancy without suggesting a
numerical scoring system. Mahmood et al. (7) used a
scoring system similar to that proposed by Jaaskleinen
et al. (4) and Rohringer et al. (5) but made the system more reproducible by establishing objective criteria
and divided meningiomas into three groups ie. typical,
atypical, malignant.

Out of 61 meningioma cases 52 (76.6%)
were scored as typical with Mahmood scoring
system and only 3 (5.8%) had recurrences.
Other 9 cases were atypical and 6 (66.6%)
had recurrences of which one turned out to
be malignant. Statistical analysis by Mann
Whitney Confidence Interval and Test considering both described parameters and final
score revealed significant increase for recurrent meningiomas. These findings highlights the routine application of Mahmood
scoring system to meningiomas for a better
prognostic determination.
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as meningioma have been reviewed and scored by the
criteria described by Mahmood et al. (7) in order to
search if the system is available for grading these cases.
Materials and Methods
Sections of specimens from 61 patients diagnosed
as meningiomas have been reviewed. A detailed review
of the patients’ age, sex distribution and location of
tumors were prepared. All the cases were typed as
described by WHO classification (6), than scored as described by Mahmood et al. (7). A summary of the
Mahmood scoring system is given in Table 1 (7). Six
histopathologic features were evaluated. These were,
hypercellularity, nuclear pleomorphism, mitosis, necrosis, loss of architecture and brain invasion (Figures
1-4). Than scores for each item described above and
the total score (Mahmood score), were analysed by
Mann Whitney Confidence Interval and Test (MWCIT)
considering cases with recurrent disease and those
without recurrences.

In this series specimens from patients diagnosed
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Table 1.

Histological
feature

score 0

score 1

score 2

score 3

hypercellularity

10 whorls/HPF*

same, except

small, close whorls (30

loss of whorls,

perivascular

whorls/HPF)

crowded nuclei

The summary of the criteria for
the scoring of meningiomas
described by Mahmood et al. (7).
Final score is reached by addition
of all the scores from each
parameter (*HPF:High power
field).

increased cellularity
nuclearf

uniform, bland

occasional large

many large cells,

Large vesicular

pleomorphism

nuclei, no

nuclei

small nucleoli

cells, prominet

nucleoli
mitosis

none

nucleoli
1,2/10HPF

3-4/10HPF

more than
5/10HPF

necrosis

loss of

none

none

rare, each less than

frequent, 1/2 to 1

Large, more than

1/2HPF

HPF

1HPF

incipient loss

ınvolving 1-2 adjacent

involving 1-2

HPF

HPF

pushing the brain not

cords infiltrating the

-

intervening menings

brain

architecture
brain invasion

absent

Figure 1.3. High power view of the fields with pleomorphism,
hypercellularity, and nuclear pleomorphism in atypical
meningioma cases (H&EX400).

Results
Out of 61 meningioma cases 35(57.1%) were females and 26(42.9%) were males. Female to male ratio was 1.3/1. The age distrubution ranged from 14
to 69 for males, 5 to 65 for females and mean age
was 50.62 for males and 47.61 for females. The
distrubution of the histological subtypes according to
WHO was as follows: 16(26.7%) meningotelial, 17
(28.3%) fibroblastic, 13(21.7%) transitional, 4(6.7%)
psammomatous, 1(1.7%) angiomatouus, 1(1.7%) met58
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The predominance of meningiomas in th female sex
is well known (8). In the series of Capadano et al.
71% of the cases were found to be occuring in females with an average age of 52.64 and 29% occurred in males with a mean age of 53.46 (10). In
this series only 57.1% of the cases were females and
the median age was a little younger than males.

Figure 4.

Necrosis and loss of achitecture in atypical meningioma
(H&EX100)

aplastic, 5(8.5%) atypical and 4(6.7%) anaplastic. One
case turned out to be sarcomatous in the recurrence.
With the Mahmood scoring system 52(76.6%) of the
cases were scored as less than 4 ie typical, and only
3(5.8%) of them had recurrences. The other 9 cases
(13.4%) had scores greater than 4 ie atypical and 6
(66.6%) of them had rcurrences. 1(1.7%) case had
multiple recurrences and turned out to be sarcomatous
reaching a score of 17 with brain invasion. But at
first operation non of the cases had brain invasion so
statistical analysis could not be performed for this feature. The analysis by MWCIT results revealed all other
features (hypercelllularity, and total Mahmood score
were significantly higher for cases with recurrences. p
value was found to be 0.0147 for nuclear pleomorphism, 0.0044 for mitosis, 0.0012 for mitosis,
0.0012 for necrosis, 0.0002 for loss of architecture,
and less than 0.0001 for hypercelllularity and total
Mahmood score. These results suggest that total score
and hypercellularity are the most valuable parameters
in predicting recurrences, followed in order by loss of
architecture, necrosis, mitosis and nuclear pleomorphism.
Discussion
Meningiomas comprise 13-19% of intracranial neoplasms and are only second in incidence to gliomas
(1,8). Their origin is generally belived to be from
aracnoidal cap cells. They are seen most frequently between 30-60 years with a mean age of 45 (9). In
this series the median age is 48.84 and 83% of the
cases were between 30-60 years.

In the series of Rohringer et al. (5) among 193
meningiomas, meningioteliomatous (38%) and transitional (33%)types were most frequently observed. In
contrast in another series (9) meningotelial (28%), fibrous (26%) and transitional (14%) types were most
frequent. In this series the most frequent types were
meningotelial (26.7%), fibrous (28.3%) and transitional (27.1%).
The greatest interest in meningiomas are about
the malignant potential and the clinical and histopathological implications. In the series of Mahmood
et al. (7) out of 276 cases, 92% were benign with a
female to male ratio of 2.3/1 and 8% were atypical
or malignant with a female to male ratio of 0.9/1,
suggesting increased malignant potential for the male
patients. In this series 15.1% of the cases were atypical or malignant but female to male ratio was 1.2/1.
The only malignant meningioma which started with a
histopathologic configuration of atypical type was a
male patient. The repotred incidence of meningiomas
in the first two decades of life is 1.8 to 6% (8,9). In
this series 3(4.8%) cases were of the first two decades of life.
New tools are available for the determinaton of
the recurrences of the meningiomas. Kunishio et al.
(11) stated that AgNOR scores or proliferative potential were significantly different between recurrent
and nonrecurrent meninigiomas. But still the grading
system according to the degree of anaplasia is of
great value and cytogenetic analysis confirmed that
complex chromosomal abnormalities and telomeric associations are observed more frequently in tumors
with anaplasia (10). Malignancy in meningiomas has
been a contravercy and some have even stated that,
biological behaviour cannot be predicted on histopathological analysis (12).
In spite of this Mahmood et al. (7) stated that
they believed it was simply a reflection of the absence
of the criteria for defining malignancy and described a
detailed scoring system. In a series of 25 atypical and
malignant meningiomas with the described criteria
Mahmood et al. (7) reported recurrences in 51.85%
and mortality in 44% of the patients during 5 to 15
59
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years follow up. In contrast only 2% of the benign
meningiomas had recurrences.
In this series all the detailed criteria described by
Mahmood et al. (7) have been applied to meningioma
cases and a high recurrence rate (66%) have been
demonstrated in atypical meningiomas. Also all parameters that could be evaluated by statistical analysis
(hypercelularity,
mitosis,necrosis,
nuclear
pleomorphism, loss of architecture) and the total score
were found valuable for determining recurrences. Of
these the lowest p value was found for hypercellularity
and total Mahmood score. These results suggest the

scoring system described by Mahmood et al (7) is valuable both at the level of each parameter and total
score. Although upto now no single histopathological
parameter have been accepted for determinig recurrences in meningiomas (4-8), these results encourage us to reevaluate our ongoing opinions. The results
obtained by few or single criteria was found unsatisfactory, which may be caused by uncertain and
obscure criteria used till now. We belive these features
should be evaluated in larger series seperately by different working groups before routine application. But
these results encourage Mahmod scoring system in
meningiomas.
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